表紙
市場調查報告書
商品編碼
1064711

Somatuline市場(2021年∼2027年)

Somatuline Market 2021-2027

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 100 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球Somatuline的市場規模在預測期間內預計將以相當的年複合成長率成長。市場成長的主要因素有有老年人口的增加,及II型糖尿病和肥胖等疾病全球性盛行率的上升等。還有高醫療費,研究開發活動的增加,及新藥銷售的FDA的認證,是推動市場增長的其他因素。

這份報告提供Somatuline市場調查,提供市場概要,市場的推動因素與阻礙因素的分析,市場機會,各類型,各用途,各地區的市場分析,主要企業的簡介等系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第4章 市場細分化

  • 全球Somatuline市場:各類型
    • 60mg
    • 90mg
    • 120mg
  • 全球Somatuline市場:各用途
    • 醫院
    • 藥局

第5章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第6章 企業簡介

  • Hoffmann La Roche, Ltd
  • International GmbH.,
  • Boehringer Ingelheim
  • Novartis AG
  • Ipsen Group
目錄
Product Code: OMR2024197

Global Somatuline Market Size, Share & Trends Analysis Report By Type(60 Mg, 90Mg, 120Mg)By Application (Hospital and Pharmacy)Forecast (2021-2027)

The global somatuline market is anticipated to grow at a considerable CAGR during the forecast period. The market growth is backed by the increasing geriatric population and growing prevalence of diseases such as diabetes mellitus type II and obesity globally. Apart from these, high healthcare expenditure, increased R&D activities, and FDA approvals to new drug launch are the other factors driving the market growth. In 2017, Somatuline® Depot (lanreotide) Injection 120 mg for the treatment of carcinoid syndrome developed by Ipsen had been approved by the US FDA. Somatuline® Depot is also approved for the improvement of progression-free survival (PFS) inpatients with unresectable, well- or moderately-differentiated, locally advanced or Metastatic gastroenteropancreatic neuroendocrine tumors.

The global somatuline market is segmented based on type and application. Based on type, the market is sub-segmented into 60 mg, 90mg, 120mg. Based on application, the market is sub-segmented into hospital and pharmacy.

Geographically, the global somatuline market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. The North American region has been dominating this market over the past few years due to factors such as high adoption rates for pharmaceutical drugs in developed countries, and rise in healthcare expenditure on chronic diseases.

Some of the companies operating in the global somatuline market include Hoffmann La Roche, Ltd., International GmbH., Boehringer Ingelheim., Novartis AG., and Ipsen Group., among others.

Market Segmentation

1. Global Somatuline Market Research and Analysis by Type

2. Global Somatuline Market Research and Analysis by Application

The Report Covers

  • Comprehensive research methodology of the global somatuline market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global somatuline market.
  • Insights about market determinants that are stimulating the global somatuline market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global Somatuline Market by Type
    • 4.1.1. 60 mg
    • 4.1.2. 90 mg
    • 4.1.3. 120 mg
  • 4.2. Global Somatuline Market by Application
    • 4.2.1. Hospital
    • 4.2.2. Pharmacy

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Hoffmann La Roche, Ltd
  • 6.2. International GmbH.,
  • 6.3. Boehringer Ingelheim
  • 6.4. Novartis AG
  • 6.5. Ipsen Group

LIST OF TABLES

  • 1. GLOBAL SOMATULINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL SOMATULINE IN 60 MG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL SOMATULINE IN 90 MG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL SOMATULINE IN 120 MG MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL SOMATULINE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2020-2027 ($ MILLION)
  • 6. GLOBAL SOMATULINE IN HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL SOMATULINE IN PHARMACY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. NORTH AMERICAN SOMATULINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 9. NORTH AMERICAN SOMATULINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 10. NORTH AMERICAN SOMATULINE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2020-2027 ($ MILLION)
  • 11. EUROPEAN SOMATULINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 12. EUROPEAN SOMATULINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 13. EUROPEAN SOMATULINE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2020-2027 ($ MILLION)
  • 14. ASIA-PACIFIC SOMATULINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 15. ASIA-PACIFIC SOMATULINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 16. ASIA-PACIFIC SOMATULINE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2020-2027 ($ MILLION)
  • 17. REST OF THE WORLD SOMATULINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 18. REST OF THE WORLD SOMATULINE MARKET RESEARCH AND ANALYSIS BY TYPE 2020-2027 ($ MILLION)
  • 19. REST OF THE WORLD SOMATULINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SOMATULINE MARKET SHARE BY TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL SOMATULINE MARKET SHARE BY APPLICATION 2020 VS 2027 (%)
  • 3. GLOBAL SOMATULINE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 4. US SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 5. CANADA SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. UK SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. FRANCE SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. GERMANY SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. ITALY SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. SPAIN SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. REST OF EUROPE SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. INDIA SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. CHINA SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. JAPAN SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. REST OF THE WORLD SOMATULINE MARKET SIZE, 2020-2027 ($ MILLION)